Ellagic Acid and Its Role in Chronic Diseases

Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 928)

Abstract

Ellagic acid is a natural anti-oxidant phenol found in numerous fruits and vegetables, in particular pomegranate, persimmon, raspberry, black raspberry, strawberry, peach, plumes, nuts (walnuts, almonds), and wine. The anti-proliferative and anti-oxidant properties of ellagic acid have prompted research into its potential health benefits. The aim of this chapter will be to summarize potential benefits of ellagic acid supplementation in chronic diseases.

Keywords

Ellagic acid Cancer Chronic inflammation Diabetes 

References

  1. 1.
    Zamora-Ros R, Knaze V, Luján-Barroso L, Slimani N, Romieu I, Fedirko V, de Magistris MS, Ericson U, Amiano P, Trichopoulou A, Dilis V, Naska A, Engeset D, Skeie G, Cassidy A, Overvad K, Peeters PH, Huerta JM, Sánchez MJ, Quirós JR, Sacerdote C, Grioni S, Tumino R, Johansson G, Johansson I, Drake I, Crowe FL, Barricarte A, Kaaks R, Teucher B, Bueno-de-Mesquita HB, van Rossum CT, Norat T, Romaguera D, Vergnaud AC, Tjønneland A, Halkjær J, Clavel-Chapelon F, Boutron-Ruault MC, Touillaud M, Salvini S, Khaw KT, Wareham N, Boeing H, Förster J, Riboli E, González CA (2011) Estimated dietary intakes of flavonols, flavanones and flavones in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24 hour dietary recall cohort. Br J Nutr 106(12):1915–1925CrossRefPubMedGoogle Scholar
  2. 2.
    Seeram NP, Zhang Y, McKeever R, Henning SM, Lee RP, Suchard MA, Li Z, Chen S, Thames G, Zerlin A, Nguyen M, Wang D, Dreher M, Heber D (2008) Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects. J Med Food 11(2):390–394CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Larrosa M, Tomás-Barberán FA, Espín JC (2006) The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem 17(9):611–625CrossRefPubMedGoogle Scholar
  4. 4.
    Gil MI, Tomás-Barberán FA, Hess-Pierce B, Holcroft DM, Kader AA (2000) Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 48(10):4581–4589CrossRefPubMedGoogle Scholar
  5. 5.
    Bala I, Bhardwaj V, Hariharan S, Kumar MN (2006) Analytical methods for assay of ellagic acid and its solubility studies. J Pharm Biomed Anal 40(1):206–210CrossRefPubMedGoogle Scholar
  6. 6.
    Marín M, Giner RM, Ríos JL, Recio MC (2013) Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodium models of mice colitis. J Ethnopharmacol 150(3):925–934CrossRefPubMedGoogle Scholar
  7. 7.
    Rosillo MA, Sánchez-Hidalgo M, Cárdeno A, Aparicio-Soto M, Sánchez-Fidalgo S, Villegas I, de la Lastra CA (2012) Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol Res 66(3):235–242CrossRefPubMedGoogle Scholar
  8. 8.
    Umesalma S, Sudhandiran G (2011) Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway. Eur J Pharmacol 660(2–3):249–258CrossRefPubMedGoogle Scholar
  9. 9.
    Xu YM, Deng JZ, Ma J, Chen SN, Marshall R, Jones SH, Johnson RK, Hecht SM (2003) DNA damaging activity of ellagic acid derivatives. Bioorg Med Chem 11:1593–1596CrossRefPubMedGoogle Scholar
  10. 10.
    Devipriya N, Sudheer AR, Menon VP (2007) Dose-response effect of ellagic acid oncirculatory antioxidants and lipids during alcohol-induced toxicity in experimental rats. Fundam Clin Pharmacol 21:621–630CrossRefPubMedGoogle Scholar
  11. 11.
    Singh K, Khanna AK, Chander R (1999) Hepatoprotective activity of ellagic acid carbon tetrachloride induced hepatotoxicity in rats. Indian J Exp Biol 37:1025–1026PubMedGoogle Scholar
  12. 12.
    Yu YM, Chang WC, Wu CS, Chiang SY (2005) Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J Nutr Biochem 16:675–681CrossRefPubMedGoogle Scholar
  13. 13.
    Pathak RK, Baunthiyal M, Taj G, Kumar A (2014) Virtual screening of natural inhibitors to the predicted HBx protein structure of Hepatitis B Virus using molecular docking for identification of potential lead molecules for liver cancer. Bioinformation 10:428–435CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Reddy BU, Mullick R, Kumar A, Sudha G, Srinivasan N, Das S (2014) Small molecule inhibitors of HCV replication from Pomegranate. Sci Rep 4:1–10CrossRefGoogle Scholar
  15. 15.
    Ajala OS, Jukov A, Ma CM (2014) Hepatitis C virus inhibitory hydrolysable tanninsfrom the fruits of Terminalia chebula. Fitoterapia 99:117–123CrossRefPubMedGoogle Scholar
  16. 16.
    Ulrich P, Cerami A (2001) Protein glycation, diabetes, and aging. Recent Prog Horm Res 56:1–21CrossRefPubMedGoogle Scholar
  17. 17.
    Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer’s disease. Nature 382(6593):685–691CrossRefPubMedGoogle Scholar
  18. 18.
    Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, Münch G (2011) Advanced glycation endproducts and their receptor RAGE in Alzheimer’s disease. Neurobiol Aging 32(5):763–777CrossRefPubMedGoogle Scholar
  19. 19.
    Liu W, Ma H, Frost L, Yuan T, Dain JA, Seeram NP (2014) Pomegranate phenolics inhibit formation of advanced glycation endproducts by scavenging reactive carbonyl species. Food Funct 5(11):2996–3004CrossRefPubMedGoogle Scholar
  20. 20.
    Rojanathammanee L, Puig KL, Combs CK (2013) Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J Nutr 143(5):597–605CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Fatima N, Hafizur RM, Hameed A, Ahmed S, Nisar M, Kabir N (2015) Ellagic acid in Emblica officinalis exerts anti-diabetic activity through the action on β-cells of pancreas. Eur J Nutr. doi: 10.1007/s00394-015-1103-y PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Internal Medicine and TherapeuticsUniversity of Pavia, Fondazione IRCCS Policlinico S. MatteoPaviaItaly
  2. 2.Center for Prevention, Surveillance, Diagnosis and Treatment of Rare DiseasesFondazione IRCCS Policlinico San MatteoPaviaItaly
  3. 3.Center for the Study of Endocrine-Metabolic Pathophysiology and Clinical ResearchUniversity of PaviaPaviaItaly
  4. 4.Laboratory of Molecular MedicineUniversity of PaviaPaviaItaly
  5. 5.PhD School in Experimental MedicineUniversity of PaviaPaviaItaly
  6. 6.Biotechnology Research CenterMashhad University of Medical SciencesMashhadIran
  7. 7.Department of Medical Biotechnology, School of MedicineMashhad University of Medical SciencesMashhadIran

Personalised recommendations